An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

IF 503.1 1区 医学 Q1 ONCOLOGY
Elshad Hasanov MD, PhD, Debra Nana Yeboa MD, Mathew D. Tucker MD, Todd A. Swanson MD, PhD, Thomas Hendrix Beckham MD, PhD, Brian Rini MD, Chibawanye I. Ene MD, PhD, Merve Hasanov MD, Sophie Derks MD, Marion Smits MD, PhD, Shaan Dudani MD, MPH, Daniel Y. C. Heng MD, MPH, Priscilla K. Brastianos MD, Axel Bex MD, PhD, Sahin Hanalioglu MD, PhD, Jeffrey S. Weinberg MD, Laure Hirsch MD, Maria I. Carlo MD, Ayal Aizer MD, MHS, Paul David Brown MD, Mehmet Asim Bilen MD, Eric Lin Chang MD, Jerry Jaboin MD, PhD, James Brugarolas MD, PhD, Toni K. Choueiri MD, Michael B. Atkins MD, Bradley A. McGregor MD, Lia M. Halasz MD, Toral R. Patel MD, Scott G. Soltys MD, David F. McDermott MD, James Bradley Elder MD, Mustafa K. Baskaya MD, James B. Yu MD, Robert Timmerman MD, Michelle Miran Kim MD, Melike Mut MD, James Markert MD, Kathryn Beal MD, Nizar M. Tannir MD, George Samandouras MD, Frederick F. Lang MD, Rachel Giles MD, Eric Jonasch MD
{"title":"An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma","authors":"Elshad Hasanov MD, PhD,&nbsp;Debra Nana Yeboa MD,&nbsp;Mathew D. Tucker MD,&nbsp;Todd A. Swanson MD, PhD,&nbsp;Thomas Hendrix Beckham MD, PhD,&nbsp;Brian Rini MD,&nbsp;Chibawanye I. Ene MD, PhD,&nbsp;Merve Hasanov MD,&nbsp;Sophie Derks MD,&nbsp;Marion Smits MD, PhD,&nbsp;Shaan Dudani MD, MPH,&nbsp;Daniel Y. C. Heng MD, MPH,&nbsp;Priscilla K. Brastianos MD,&nbsp;Axel Bex MD, PhD,&nbsp;Sahin Hanalioglu MD, PhD,&nbsp;Jeffrey S. Weinberg MD,&nbsp;Laure Hirsch MD,&nbsp;Maria I. Carlo MD,&nbsp;Ayal Aizer MD, MHS,&nbsp;Paul David Brown MD,&nbsp;Mehmet Asim Bilen MD,&nbsp;Eric Lin Chang MD,&nbsp;Jerry Jaboin MD, PhD,&nbsp;James Brugarolas MD, PhD,&nbsp;Toni K. Choueiri MD,&nbsp;Michael B. Atkins MD,&nbsp;Bradley A. McGregor MD,&nbsp;Lia M. Halasz MD,&nbsp;Toral R. Patel MD,&nbsp;Scott G. Soltys MD,&nbsp;David F. McDermott MD,&nbsp;James Bradley Elder MD,&nbsp;Mustafa K. Baskaya MD,&nbsp;James B. Yu MD,&nbsp;Robert Timmerman MD,&nbsp;Michelle Miran Kim MD,&nbsp;Melike Mut MD,&nbsp;James Markert MD,&nbsp;Kathryn Beal MD,&nbsp;Nizar M. Tannir MD,&nbsp;George Samandouras MD,&nbsp;Frederick F. Lang MD,&nbsp;Rachel Giles MD,&nbsp;Eric Jonasch MD","doi":"10.3322/caac.21729","DOIUrl":null,"url":null,"abstract":"<p>Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited understanding of brain metastasis tumor and immune biology, drivers of resistance to systemic treatment, and their overall poor prognosis. Current data support a multimodal treatment strategy with radiation treatment and/or surgery. Nonetheless, the optimal approach for the management of brain metastases from renal cell carcinoma remains unclear. To improve patient care, the authors sought to standardize practical management strategies. They performed an unstructured literature review and elaborated on the current management strategies through an international group of experts from different disciplines assembled via the network of the International Kidney Cancer Coalition. Experts from different disciplines were administered a survey to answer questions related to current challenges and unmet patient needs. On the basis of the integrated approach of literature review and survey study results, the authors built algorithms for the management of single and multiple brain metastases in patients with renal cell carcinoma. The literature review, consensus statements, and algorithms presented in this report can serve as a framework guiding treatment decisions for patients. <b>CA Cancer J Clin. 2022;72:454-489.</b></p>","PeriodicalId":137,"journal":{"name":"CA: A Cancer Journal for Clinicians","volume":null,"pages":null},"PeriodicalIF":503.1000,"publicationDate":"2022-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.3322/caac.21729","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CA: A Cancer Journal for Clinicians","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.3322/caac.21729","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 11

Abstract

Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited understanding of brain metastasis tumor and immune biology, drivers of resistance to systemic treatment, and their overall poor prognosis. Current data support a multimodal treatment strategy with radiation treatment and/or surgery. Nonetheless, the optimal approach for the management of brain metastases from renal cell carcinoma remains unclear. To improve patient care, the authors sought to standardize practical management strategies. They performed an unstructured literature review and elaborated on the current management strategies through an international group of experts from different disciplines assembled via the network of the International Kidney Cancer Coalition. Experts from different disciplines were administered a survey to answer questions related to current challenges and unmet patient needs. On the basis of the integrated approach of literature review and survey study results, the authors built algorithms for the management of single and multiple brain metastases in patients with renal cell carcinoma. The literature review, consensus statements, and algorithms presented in this report can serve as a framework guiding treatment decisions for patients. CA Cancer J Clin. 2022;72:454-489.

肾细胞癌患者脑转移治疗的跨学科共识
脑转移是肾细胞癌的一种具有挑战性的表现。我们对脑转移瘤和免疫生物学的了解有限,对全身治疗的抵抗驱动因素,以及它们的整体预后不良。目前的数据支持放射治疗和/或手术的多模式治疗策略。尽管如此,治疗肾细胞癌脑转移的最佳方法仍不清楚。为了改善病人的护理,作者试图标准化实用的管理策略。他们进行了一项非结构化的文献综述,并通过国际肾癌联盟网络聚集了来自不同学科的国际专家小组,详细阐述了当前的管理策略。来自不同学科的专家接受了一项调查,以回答与当前挑战和未满足的患者需求相关的问题。在文献回顾和调查研究结果相结合的基础上,作者构建了肾细胞癌患者单发和多发脑转移的处理算法。本报告中提出的文献综述、共识声明和算法可以作为指导患者治疗决策的框架。中华肿瘤学杂志,2010;32(2):444 - 444。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
873.20
自引率
0.10%
发文量
51
审稿时长
1 months
期刊介绍: CA: A Cancer Journal for Clinicians" has been published by the American Cancer Society since 1950, making it one of the oldest peer-reviewed journals in oncology. It maintains the highest impact factor among all ISI-ranked journals. The journal effectively reaches a broad and diverse audience of health professionals, offering a unique platform to disseminate information on cancer prevention, early detection, various treatment modalities, palliative care, advocacy matters, quality-of-life topics, and more. As the premier journal of the American Cancer Society, it publishes mission-driven content that significantly influences patient care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信